Oct 13 (Reuters) - Fagron NV FAGRO.BR :
* Q3-2020: TURNOVER GROWTHOF 10.7% CER TO EUR 135.1 MILLION
* STRONG PERFORMANCE, PARTICULARLY IN LATIN AMERICA; NORTH AMERICA ALSO REPORTS GOOD GROWTH
IN
TURNOVER
* SIGNIFICANT WEAKENING OF BRL AND MXN AGAINST EUR RESULTS IN REPORTED TURNOVER DECLINE OF
0.4% IN
Q3
* IMPACT OF COVID-19 PANDEMIC REMAINED LIMITED AND NON-MATERIAL IN Q3
* ACQUISITION OF PHARMA TAMAR IN ISRAEL COMPLETED IN AUGUST
* THERE HAVE BEEN VIRTUALLY NO DISRUPTIONS TO FAGRON’S SUPPLY CHAIN AS A RESULT OF COVID-19
* COMING QUARTER WILL ALSO BE DOMINATED BY COVID-19 AND VISIBILITY IS LIMITED
Source text for Eikon: ID:nGNE3vzh1J
Further company coverage: FAGRO.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))